Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Rebuttal from Dr Lam.

Lam DCL.

Chest. 2013 Mar;143(3):603-604. doi: 10.1378/chest.12-2549. No abstract available.

PMID:
23460152
2.

Epidermal growth factor receptor mutations detected in tumors from Chinese "never smokers" with lung adenocarcinoma.

Ren GP, Wang TY, Pan QL, Pao W, Huai J.

Chin Med J (Engl). 2005 May 5;118(9):769-71. No abstract available.

PMID:
15899142
3.

Spectrum of EGFR mutation in lung adenocarcinoma in Morocco.

Elghissassi I, Errihani H.

J Thorac Oncol. 2013 Dec;8(12):e115-6. doi: 10.1097/JTO.0000000000000023. No abstract available.

4.

Spectrum of EGFR mutation in lung adenocarcinoma in Morocco.

Ismaili N, Belbaraka R.

J Thorac Oncol. 2013 Dec;8(12):e114-5. doi: 10.1097/JTO.0000000000000014. No abstract available.

5.

Crossing the rubicon in lung adenocarcinoma: the conundrum of EGFR tyrosine kinase mutations.

Rosell R, Felip E, Reguart N, Moran T.

Future Oncol. 2005 Jun;1(3):319-22. Review. No abstract available.

PMID:
16556005
6.

Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma.

Mohapatra PR, Punatar S, Prabhash K.

Eur Respir J. 2012 Jun;39(6):1550-1; author reply 1551. doi: 10.1183/09031936.00022112. No abstract available.

7.

Do complex mutations of the epidermal growth factor receptor gene reflect intratumoral heterogeneity?

Hata A, Fujita S, Kaji R, Katakami N, Imai Y.

J Thorac Oncol. 2011 Jun;6(6):1144-6. doi: 10.1097/JTO.0b013e31821b1194. No abstract available.

8.

Evolutionary Precision Medicine: A Role for Repeat Epidermal Growth Factor Receptor Analysis in ALK-Rearranged Lung Adenocarcinoma?

Birkbak NJ, Hiley CT, Swanton C.

J Clin Oncol. 2015 Nov 10;33(32):3681-3. doi: 10.1200/JCO.2015.63.2976. Epub 2015 Sep 28. No abstract available.

PMID:
26417000
9.

Pulmonary adenocarcinomas with mutant epidermal growth factor receptors.

Riemenschneider MJ, Bell DW, Haber DA, Louis DN.

N Engl J Med. 2005 Apr 21;352(16):1724-5. No abstract available.

10.

EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome.

Bemis LT, Robinson WA, McFarlane R, Buyers E, Kelly K, Varella-Garcia M, Mitchell JD, Franklin WA.

Lancet Oncol. 2007 Jun;8(6):559-60. No abstract available.

PMID:
17540308
11.

EGFR mutations in Asian patients with advanced lung adenocarcinoma.

Liam CK, Pang YK, Poh ME.

J Thorac Oncol. 2014 Sep;9(9):e70-1. doi: 10.1097/JTO.0000000000000251. No abstract available.

12.

Lung carcinoma morphology or mutational profile: that is the question.

Dacic S.

Arch Pathol Lab Med. 2011 Oct;135(10):1242-3. doi: 10.5858/arpa.2011-0223-ED. No abstract available.

PMID:
21970476
13.

Multiple nodular pulmonary metastases of lung adenocarcinoma with epidermal growth factor receptor mutation.

Kawata N, Inoue M, Horita N, Tomaru K, Yamamoto M, Sato T, Miyazawa N, Kaneko T.

Respir Investig. 2016 Mar;54(2):133-5. doi: 10.1016/j.resinv.2015.09.006. Epub 2015 Nov 20. No abstract available.

PMID:
26879485
14.

[Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Pro].

Brückl W.

Dtsch Med Wochenschr. 2012 Mar;137(12):592. doi: 10.1055/s-0031-1298873. Epub 2012 Mar 13. German. No abstract available.

PMID:
22415622
15.

Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule.

Nakano H, Soda H, Takasu M, Tomonaga N, Yamaguchi H, Nakatomi K, Fujino S, Hayashi T, Nakamura Y, Tsukamoto K, Kohno S.

Lung Cancer. 2008 Apr;60(1):136-40. Epub 2007 Sep 24.

PMID:
17889960
16.

[Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Contra].

von Pawel J.

Dtsch Med Wochenschr. 2012 Mar;137(12):593. doi: 10.1055/s-0031-1298877. Epub 2012 Mar 13. German. No abstract available.

PMID:
22415623
17.

In response.

Shi Y, Yang PC.

J Thorac Oncol. 2014 Jul;9(7):e58-9. doi: 10.1097/JTO.0000000000000237. No abstract available.

18.

To the editor.

Ou SH.

J Thorac Oncol. 2014 Jul;9(7):e57-8. doi: 10.1097/JTO.0000000000000192. No abstract available.

19.
20.

Differences in the Epidemiology of Rare EGFR Mutations in Different Populations.

Lohinai Z, Ostoros G, Moldvay J, Dome B, Hegedus B.

J Thorac Oncol. 2016 Jan;11(1):e19-20. doi: 10.1016/j.jtho.2015.09.003. No abstract available.

Supplemental Content

Support Center